Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Successful elevation of circulating acetate and propionate by dietary modulation does not alter T-regulatory cell or cytokine profiles in healthy humans: a pilot study.

Gill PA, van Zelm MC, Ffrench RA, Muir JG, Gibson PR.

Eur J Nutr. 2019 Oct 24. doi: 10.1007/s00394-019-02113-2. [Epub ahead of print]

PMID:
31650328
2.

Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real-world experience.

Tuck CJ, Reed DE, Muir JG, Vanner SJ.

Neurogastroenterol Motil. 2020 Jan;32(1):e13730. doi: 10.1111/nmo.13730. Epub 2019 Sep 30.

PMID:
31571351
3.

Intestinal gases: influence on gut disorders and the role of dietary manipulations.

Kalantar-Zadeh K, Berean KJ, Burgell RE, Muir JG, Gibson PR.

Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):733-747. doi: 10.1038/s41575-019-0193-z. Epub 2019 Sep 13. Review.

PMID:
31520080
4.

Dietary fat and the faecal microbiome: where collinearity may lead to incorrect attribution of effects to fat.

Ardalan ZS, Sparrow MP, Muir JG, Gibson PR.

Gut. 2019 Sep 6. pii: gutjnl-2019-319628. doi: 10.1136/gutjnl-2019-319628. [Epub ahead of print] No abstract available.

PMID:
31492690
5.

The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome.

Tuck CJ, Caminero A, Jiménez Vargas NN, Soltys CL, Jaramillo Polanco JO, Lopez Lopez CD, Constante M, Lourenssen SR, Verdu EF, Muir JG, Lomax AE, Reed DE, Vanner SJ.

Neurogastroenterol Motil. 2019 Oct;31(10):e13675. doi: 10.1111/nmo.13675. Epub 2019 Jul 9.

PMID:
31290223
6.

Prebiotics Versus Low FODMAP Diet: An Interpretative Nightmare.

Varney J, Muir JG, Gibson PR.

Gastroenterology. 2019 Mar;156(4):1222. doi: 10.1053/j.gastro.2018.10.060. Epub 2018 Dec 10. No abstract available.

PMID:
30543795
7.

Gluten-free and low-FODMAP sourdoughs for patients with coeliac disease and irritable bowel syndrome: A clinical perspective.

Muir JG, Varney JE, Ajamian M, Gibson PR.

Int J Food Microbiol. 2019 Feb 2;290:237-246. doi: 10.1016/j.ijfoodmicro.2018.10.016. Epub 2018 Oct 24.

PMID:
30388591
8.

Randomised clinical trial: reducing the intake of dietary FODMAPs of breastfeeding mothers is associated with a greater improvement of the symptoms of infantile colic than for a typical diet.

Iacovou M, Craig SS, Yelland GW, Barrett JS, Gibson PR, Muir JG.

Aliment Pharmacol Ther. 2018 Nov;48(10):1061-1073. doi: 10.1111/apt.15007. Epub 2018 Oct 10.

PMID:
30306603
9.

Culture- and metagenomics-enabled analyses of the Methanosphaera genus reveals their monophyletic origin and differentiation according to genome size.

Hoedt EC, Parks DH, Volmer JG, Rosewarne CP, Denman SE, McSweeney CS, Muir JG, Gibson PR, Cuív PÓ, Hugenholtz P, Tyson GW, Morrison M.

ISME J. 2018 Dec;12(12):2942-2953. doi: 10.1038/s41396-018-0225-7. Epub 2018 Aug 1.

10.

The safety and sensitivity of a telemetric capsule to monitor gastrointestinal hydrogen production in vivo in healthy subjects: a pilot trial comparison to concurrent breath analysis.

Berean KJ, Ha N, Ou JZ, Chrimes AF, Grando D, Yao CK, Muir JG, Ward SA, Burgell RE, Gibson PR, Kalantar-Zadeh K.

Aliment Pharmacol Ther. 2018 Sep;48(6):646-654. doi: 10.1111/apt.14923. Epub 2018 Aug 1.

11.

Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders.

Gill PA, van Zelm MC, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2018 Jul;48(1):15-34. doi: 10.1111/apt.14689. Epub 2018 May 3. Review.

12.

Modulation of colonic hydrogen sulfide production by diet and mesalazine utilizing a novel gas-profiling technology.

Yao CK, Rotbart A, Ou JZ, Kalantar-Zadeh K, Muir JG, Gibson PR.

Gut Microbes. 2018 Nov 2;9(6):510-522. doi: 10.1080/19490976.2018.1451280. Epub 2018 May 9.

13.

Editorial: irritable bowel syndrome-in addition to having properly-trained dietitians, is it time to add a yoga teacher to our multidisciplinary team?

Muir JG, Iacovou M.

Aliment Pharmacol Ther. 2018 Feb;47(3):432-433. doi: 10.1111/apt.14448. No abstract available.

14.

Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity.

Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, Veierød MB, Henriksen C, Lundin KEA.

Gastroenterology. 2018 Feb;154(3):529-539.e2. doi: 10.1053/j.gastro.2017.10.040. Epub 2017 Nov 2.

PMID:
29102613
15.

Gastrointestinal Symptoms and FODMAP Intake of Aged-Care Residents from Christchurch, New Zealand.

Nanayakkara WS, Gearry RB, Muir JG, O'Brien L, Wilkinson TJ, Williman JA, Skidmore PML.

Nutrients. 2017 Sep 29;9(10). pii: E1083. doi: 10.3390/nu9101083.

16.

Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.

Tuck CJ, Taylor KM, Gibson PR, Barrett JS, Muir JG.

Am J Gastroenterol. 2018 Jan;113(1):124-134. doi: 10.1038/ajg.2017.245. Epub 2017 Aug 15.

PMID:
28809383
17.

Inaccuracy of patient-reported descriptions of and satisfaction with bowel actions in irritable bowel syndrome.

Halmos EP, Biesiekierski JR, Newnham ED, Burgell RE, Muir JG, Gibson PR.

Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13187. Epub 2017 Aug 10.

PMID:
28799291
18.

Dietary practices and FODMAPs in South Asia: Applicability of the low FODMAP diet to patients with irritable bowel syndrome.

Hewawasam SP, Iacovou M, Muir JG, Gibson PR.

J Gastroenterol Hepatol. 2018 Feb;33(2):365-374. doi: 10.1111/jgh.13885. Review.

PMID:
28700090
19.

Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right.

Gibson PR, Halmos EP, Muir JG.

Aliment Pharmacol Ther. 2017 Aug;46(3):385-386. doi: 10.1111/apt.14150. No abstract available.

20.

Reducing the maternal dietary intake of indigestible and slowly absorbed short-chain carbohydrates is associated with improved infantile colic: a proof-of-concept study.

Iacovou M, Mulcahy EC, Truby H, Barrett JS, Gibson PR, Muir JG.

J Hum Nutr Diet. 2018 Apr;31(2):256-265. doi: 10.1111/jhn.12488. Epub 2017 Jun 20.

PMID:
28631347
21.

Controversies and Recent Developments of the Low-FODMAP Diet.

Hill P, Muir JG, Gibson PR.

Gastroenterol Hepatol (N Y). 2017 Jan;13(1):36-45.

22.

FODMAPs: food composition, defining cutoff values and international application.

Varney J, Barrett J, Scarlata K, Catsos P, Gibson PR, Muir JG.

J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:53-61. doi: 10.1111/jgh.13698. Review.

PMID:
28244665
23.

Editorial: gut-directed hypnotherapy or low FODMAP diet for the treatment of irritable bowel syndrome? Authors' reply.

Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2016 Oct;44(8):902-3. doi: 10.1111/apt.13791. No abstract available.

24.

Potential of in vivo real-time gastric gas profiling: a pilot evaluation of heat-stress and modulating dietary cinnamon effect in an animal model.

Ou JZ, Cottrell JJ, Ha N, Pillai N, Yao CK, Berean KJ, Ward SA, Grando D, Muir JG, Harrison CJ, Wijesiriwardana U, Dunshea FR, Gibson PR, Kalantar-Zadeh K.

Sci Rep. 2016 Sep 16;6:33387. doi: 10.1038/srep33387.

25.
26.

Challenges of Quantifying FODMAPs in Enteral Nutrition Formulas: Evaluation of Artifacts and Solutions.

Halmos EP, Bogatyrev A, Ly E, Liels KL, Muir JG, Gibson PR.

JPEN J Parenter Enteral Nutr. 2017 Nov;41(8):1262-1271. doi: 10.1177/0148607116658763. Epub 2016 Jul 12.

PMID:
27406943
27.

Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome.

Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2016 Sep;44(5):447-59. doi: 10.1111/apt.13706. Epub 2016 Jul 11.

28.

Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets.

Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Muir JG, Gibson PR.

Clin Transl Gastroenterol. 2016 Apr 14;7:e164. doi: 10.1038/ctg.2016.22.

29.

Diet Therapy for Irritable Bowel Syndrome: Is a Diet Low in FODMAPS Really Similar in Efficacy to Traditional Dietary Advice?

Gibson PR, Varney JE, Muir JG.

Gastroenterology. 2016 Apr;150(4):1046-7. doi: 10.1053/j.gastro.2015.10.053. Epub 2016 Mar 2. No abstract available.

PMID:
26944508
30.

Review article: insights into colonic protein fermentation, its modulation and potential health implications.

Yao CK, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2016 Jan;43(2):181-96. doi: 10.1111/apt.13456. Epub 2015 Nov 2. Review.

31.

Intestinal Gas Capsules: A Proof-of-Concept Demonstration.

Kalantar-Zadeh K, Yao CK, Berean KJ, Ha N, Ou JZ, Ward SA, Pillai N, Hill J, Cottrell JJ, Dunshea FR, McSweeney C, Muir JG, Gibson PR.

Gastroenterology. 2016 Jan;150(1):37-9. doi: 10.1053/j.gastro.2015.07.072. Epub 2015 Oct 28. No abstract available.

PMID:
26518389
32.

The Low FODMAP Diet and Its Application in East and Southeast Asia.

Iacovou M, Tan V, Muir JG, Gibson PR.

J Neurogastroenterol Motil. 2015 Oct 1;21(4):459-70. doi: 10.5056/jnm15111.

33.

Other Dietary Confounders: FODMAPS et al.

Gibson PR, Muir JG, Newnham ED.

Dig Dis. 2015;33(2):269-76. doi: 10.1159/000371401. Epub 2015 Apr 22. Review.

PMID:
25925934
34.

Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease.

Peters SL, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2015 Jun;41(11):1104-15. doi: 10.1111/apt.13202. Epub 2015 Apr 10. Review.

35.

Human intestinal gas measurement systems: in vitro fermentation and gas capsules.

Ou JZ, Yao CK, Rotbart A, Muir JG, Gibson PR, Kalantar-zadeh K.

Trends Biotechnol. 2015 Apr;33(4):208-13. doi: 10.1016/j.tibtech.2015.02.002. Epub 2015 Mar 12. Review.

PMID:
25772639
36.

Food components and irritable bowel syndrome.

Gibson PR, Varney J, Malakar S, Muir JG.

Gastroenterology. 2015 May;148(6):1158-74.e4. doi: 10.1053/j.gastro.2015.02.005. Epub 2015 Feb 11. Review.

PMID:
25680668
37.

Abnormal fibre usage in UC in remission.

James SL, Christophersen CT, Bird AR, Conlon MA, Rosella O, Gibson PR, Muir JG.

Gut. 2015 Apr;64(4):562-70. doi: 10.1136/gutjnl-2014-307198. Epub 2014 Jul 18.

PMID:
25037189
38.

Diets that differ in their FODMAP content alter the colonic luminal microenvironment.

Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG.

Gut. 2015 Jan;64(1):93-100. doi: 10.1136/gutjnl-2014-307264. Epub 2014 Jul 12.

PMID:
25016597
39.

Editorial: Noncoeliac gluten sensitivity--a disease of the mind or gut? Authors' reply.

Peters SL, Biesiekierski JR, Yelland GW, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2014 Jul;40(1):114-5. doi: 10.1111/apt.12805. No abstract available.

40.

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.

Tuck CJ, Muir JG, Barrett JS, Gibson PR.

Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):819-34. doi: 10.1586/17474124.2014.917956. Epub 2014 May 15. Review.

PMID:
24830318
41.

Reply: To PMID 24076059.

Halmos EP, Muir JG, Gibson PR.

Gastroenterology. 2014 Jun;146(7):1830-1. doi: 10.1053/j.gastro.2014.04.034. Epub 2014 Apr 26. No abstract available.

PMID:
24780211
42.

Characterization of Adults With a Self-Diagnosis of Nonceliac Gluten Sensitivity.

Biesiekierski JR, Newnham ED, Shepherd SJ, Muir JG, Gibson PR.

Nutr Clin Pract. 2014 Aug;29(4):504-509. Epub 2014 Apr 16.

PMID:
24740495
43.

Randomised clinical trial: gluten may cause depression in subjects with non-coeliac gluten sensitivity - an exploratory clinical study.

Peters SL, Biesiekierski JR, Yelland GW, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2014 May;39(10):1104-12. doi: 10.1111/apt.12730. Epub 2014 Apr 1.

44.

Non-nutritional effects of food: an underutilized and understudied therapeutic tool in chronic gastrointestinal diseases.

Gibson PR, Muir JG.

J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:37-40. doi: 10.1111/jgh.12253. Review.

PMID:
24251702
45.

Functional bowel symptoms and diet.

Gibson PR, Barrett JS, Muir JG.

Intern Med J. 2013 Oct;43(10):1067-74. doi: 10.1111/imj.12266. Review.

PMID:
24134168
46.

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.

Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG.

Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25.

PMID:
24076059
47.

Pathogenesis of colonic diverticulosis: repainting the picture.

Burgell RE, Muir JG, Gibson PR.

Clin Gastroenterol Hepatol. 2013 Dec;11(12):1628-30. doi: 10.1016/j.cgh.2013.08.046. Epub 2013 Sep 10. No abstract available.

PMID:
24036057
48.

Is gluten a cause of gastrointestinal symptoms in people without celiac disease?

Biesiekierski JR, Muir JG, Gibson PR.

Curr Allergy Asthma Rep. 2013 Dec;13(6):631-8. doi: 10.1007/s11882-013-0386-4. Review.

PMID:
24026574
49.

The Low FODMAP Diet for Treatment of Irritable Bowel Syndrome and Other Gastrointestinal Disorders.

Muir JG, Gibson PR.

Gastroenterol Hepatol (N Y). 2013 Jul;9(7):450-2. No abstract available.

50.

Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome.

Yao CK, Tan HL, van Langenberg DR, Barrett JS, Rose R, Liels K, Gibson PR, Muir JG.

J Hum Nutr Diet. 2014 Apr;27 Suppl 2:263-75. doi: 10.1111/jhn.12144. Epub 2013 Aug 3.

PMID:
23909813

Supplemental Content

Support Center